~~<i id='1426F57A22'><strike id='1426F57A22'><tt id='1426F57A22'><pre id='1426F57A22'></pre></tt></strike></i>~~

Home» focus» explore

explore

author：leisure time 2025-09-29 16:38:58 Page View：698

Adam's take main illustration — Molly Ferguson/STAT

Biotech is awash in PIPEs.

The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New chief aims to remake Sanofi Genzyme
Next article： George Santos makes 1st court appearance after pleading not guilty to 13 counts

explore

Bright Health sells Medicare Advantage business to Molina

BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

Paxlovid study fails to answer questions over benefit for broader groups

KobiWolf/BloombergPfizersaidTuesdaythatamuch-watchedstudyofitsantiviralPaxlovidinpatientswhohaveCovi

In age of alternative facts, a scholarly course on calling out crap

Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

Colonoscopy at 40? Study finds a possible benefit

Dr.PedroJoseGreer,right,preparingtodoacolonoscopyatMercyHospitalinMiami.LynneSladky/APNearly15percen